OR Royalties Inc. (TSX:OR)

Verve Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,223	4,858	3,501	3,002	2,577	2,692
Market Cap Growth	37.45%	38.74%	16.65%	16.49%	-4.28%	35.46%
Enterprise Value	7,247	4,872	3,748	3,007	3,009	2,941
Last Close Price	38.53	25.92	18.62	15.87	14.83	15.24
PE Ratio	162.73	207.55	-	-	-	159.52
Forward PE	35.16	30.11	34.10	36.51	33.14	28.39
PS Ratio	25.00	17.66	14.47	13.78	11.46	12.60
PB Ratio	4.14	2.84	2.13	1.73	1.45	1.46
P/TBV Ratio	4.42	3.04	2.28	1.85	1.69	1.67
P/FCF Ratio	30.76	21.11	19.15	27.30	24.29	74.89
P/OCF Ratio	29.80	21.11	19.15	27.30	24.29	24.93
PEG Ratio	-	1.66	1.66	1.66	0.97	0.90
EV/Sales Ratio	25.08	17.71	15.49	13.81	13.38	13.77
EV/EBITDA Ratio	34.56	20.97	19.86	16.97	18.29	25.59
EV/EBIT Ratio	79.37	43.23	44.02	24.45	26.83	70.52
EV/FCF Ratio	30.87	21.17	20.50	27.35	28.37	81.81
Debt / Equity Ratio	0.07	0.08	0.12	0.09	0.23	0.22
Debt / EBITDA Ratio	0.47	0.61	1.06	0.88	2.49	3.58
Debt / FCF Ratio	0.49	0.62	1.09	1.42	3.87	11.46
Asset Turnover	0.14	0.13	0.12	0.10	0.09	0.10
Inventory Turnover	-	-	1243.20	1.73	2.63	10.91
Quick Ratio	4.87	4.26	4.02	5.72	0.38	2.91
Current Ratio	4.99	4.37	4.11	5.87	0.44	3.06
Return on Equity (ROE)	2.51%	1.33%	-2.92%	4.85%	4.23%	0.97%
Return on Assets (ROA)	3.85%	3.42%	2.69%	3.52%	2.94%	1.20%
Return on Capital (ROIC)	4.12%	3.64%	2.84%	3.76%	3.16%	1.27%
Return on Capital Employed (ROCE)	6.30%	5.70%	4.40%	6.20%	5.50%	1.80%
Earnings Yield	0.61%	0.48%	-1.41%	-3.96%	-0.91%	0.63%
FCF Yield	3.25%	4.74%	5.22%	3.66%	4.12%	1.33%
Dividend Yield	0.67%	0.98%	1.26%	1.39%	1.42%	1.31%
Payout Ratio	99.49%	188.42%	-	-	-	171.33%
Buyback Yield / Dilution	-1.40%	-1.38%	-2.43%	-7.77%	-3.20%	-7.38%
Total Shareholder Return	-0.73%	-0.39%	-1.16%	-6.38%	-1.79%	-6.07%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.